- Home
- PRQR vs CUB Comparison
PRQR vs CUB Comparison
Compare PRQR & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- CUB
- Stock Information
- Founded
- PRQR 2012
- CUB 2024
- Country
- PRQR Netherlands
- CUB United States
- Employees
- PRQR N/A
- CUB N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- CUB
- Sector
- PRQR Health Care
- CUB
- Exchange
- PRQR Nasdaq
- CUB NYSE
- Market Cap
- PRQR 309.5M
- CUB 307.3M
- IPO Year
- PRQR 2014
- CUB 2024
- Fundamental
- Price
- PRQR $3.62
- CUB $10.04
- Analyst Decision
- PRQR Strong Buy
- CUB
- Analyst Count
- PRQR 4
- CUB 0
- Target Price
- PRQR $7.13
- CUB N/A
- AVG Volume (30 Days)
- PRQR 635.3K
- CUB 15.9K
- Earning Date
- PRQR 11-07-2024
- CUB 01-01-0001
- Dividend Yield
- PRQR N/A
- CUB N/A
- EPS Growth
- PRQR N/A
- CUB N/A
- EPS
- PRQR N/A
- CUB N/A
- Revenue
- PRQR $20,506,357.00
- CUB N/A
- Revenue This Year
- PRQR $298.83
- CUB N/A
- Revenue Next Year
- PRQR N/A
- CUB N/A
- P/E Ratio
- PRQR N/A
- CUB N/A
- Revenue Growth
- PRQR 306.68
- CUB N/A
- 52 Week Low
- PRQR $1.18
- CUB $9.96
- 52 Week High
- PRQR $4.62
- CUB $10.49
- Technical
- Relative Strength Index (RSI)
- PRQR 54.60
- CUB N/A
- Support Level
- PRQR $3.57
- CUB N/A
- Resistance Level
- PRQR $3.70
- CUB N/A
- Average True Range (ATR)
- PRQR 0.22
- CUB 0.00
- MACD
- PRQR -0.08
- CUB 0.00
- Stochastic Oscillator
- PRQR 18.06
- CUB 0.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.